Short answer · Medically reviewed summary · Last updated: 2023-07-13
Infantile Myofibromatosis is a rare condition characterized by the development of benign tumors in various parts of the body. It primarily affects infants and young children, with the majority of cases diagnosed within the first year of life.
What is the prevalence of Infantile Myofibromatosis?
Prevalence of Infantile Myofibromatosis: how many people are affected worldwide, differences by sex and region, with sources.
Infantile Myofibromatosis is a rare condition characterized by the development of benign tumors in various parts of the body. It primarily affects infants and young children, with the majority of cases diagnosed within the first year of life.
The prevalence of Infantile Myofibromatosis is estimated to be around 1 in 150,000 to 1 in 400,000 births. Although it is considered a rare condition, it is important to note that the actual prevalence may be higher due to underdiagnosis or misdiagnosis.
Infantile Myofibromatosis can manifest as solitary or multiple tumors, which can occur in different organs such as the skin, muscle, bone, or internal organs. The tumors can vary in size and may cause various symptoms depending on their location and size.
While the exact cause of Infantile Myofibromatosis is unknown, some cases have been associated with genetic mutations. It is crucial for affected individuals to receive appropriate medical care and monitoring to manage the condition and its potential complications.
